Recto-vaginal Fistula Treatment Market Outlook 2031

  • The global recto-vaginal fistula treatment market was valued at US$ 550.8 Mn in 2020
  • It is estimated to expand at a CAGR of 5.7% from 2021 to 2031
  • The global recto-vaginal fistula treatment market is expected to cross the value of US$ 1 Bn by the end of 2031

Analysts’ Viewpoint on Recto-vaginal Fistula Treatment Market Scenario

Elective procedures have been postponed indefinitely in the recto-vaginal fistula treatment market due to the ongoing coronavirus pandemic. Healthcare stakeholders are increasing the availability of tests such as contrast tests, blue dye test, and CT scan to identify fistulas. However, the high number of morbidity and mortality even after recto-vaginal fistula treatment is emerging as a challenge to healthcare practitioners. Hence, practitioners should increase awareness about pre-appointment restrictions, considerations for surgery and listing key medical information to enable proper diagnosis of recto-vaginal fistula. It has been found that presence of cancerous tumor in regions such as uterus, rectum, vagina, anal canal or cervix, can lead to the development of recto-vaginal fistula.

Childbirth Injuries and Crohn’s Disease Fuel Demand for Recto-vaginal Fistula Treatment Options

The rise in prevalence of Crohn’s disease resulting in the occurrence of recto-vaginal fistula is driving the global recto-vaginal fistula treatment market. Crohn's disease can be defined as an inflammatory bowel disease, wherein there is an inflammation of the digestive tract lining. A large number of women suffering from Crohn’s disease never develop recto-vaginal fistula. However, suffering from Crohn’s disease increases the risk of this condition. Hence, the prevalence of recto-vaginal fistula is projected to rise during the forecast period, owing to the increase in incidence of Crohn’s disease.

Delivery-related injuries is a most common factor causing recto-vaginal fistulas. This includes perineum tear that extends to the bowel or an episiotomy infection, which is a surgical incision conducted to enlarge the perineum during the course of vaginal delivery. These could occur post a long, difficult, or otherwise obstructed labor. These kinds of fistula could also comprise injury to anal sphincter, the muscle rings at the end of the rectum that aids a person to hold. Hence, the incidence rate of recto-vaginal fistula is likely to increase due to rise in the rate of childbirth injuries during the forecast period. Such findings are steering the growth of the recto-vaginal fistula treatment market.

Request a sample to get extensive insights into the Recto-vaginal Fistula Treatment Market

Home Remedies and Telehealth Ensure Revenue Growth Post COVID-19 Pandemic

Stakeholders in the recto-vaginal fistula treatment market are adopting contingency planning to prevent disruption across patient demands, supply of materials, and availability of diagnostic services. Since elective procedures have been postponed indefinitely due to the ongoing coronavirus pandemic, medical practitioners are increasing awareness about different tests for identifying fistulas, medications, and lifestyle or home remedies to reduce burden on healthcare facilities. As such, telehealth and mobile apps are anticipated to register high growth post the pandemic. Healthcare stakeholders are striking a balanced relationship with suppliers and ecosystem partners to improve medical outcomes. They are increasing the availability of life-altering therapeutics.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Healthcare Stakeholders Invest in R&D to Increase Treatment Options

Recto-vaginal fistula can be described as abnormal epithelial line connected between the rectum and vagina. Fistulas can be the outcome of acquired etiologies or congenital malformations. Recto-vaginal fistulas can also be caused due to childbirth. Obstetric injury with a fourth or a third degree perineal tear or prolonged labor with necrosis of the part or episiotomy could result in recto-vaginal fistula. Infection, breakdown of the repair, or improper repair can lead to the development of fistula. Infections caused within the recto-vaginal septum can lead to the condition. Bartholin gland infections and crypto-glandular ano-rectal abscess drains cause low recto-vaginal fistula. This explains why the recto-vaginal fistula treatment market is positioned for healthy growth during the forecast period.

Hysterectomy is performed as a result of infection caused due to fistula. Lymph granuloma venereum and tuberculosis can result in recto-vaginal fistula. Primary classification of the condition is carried out with the help of etiology, size, and location. It categorizes the criteria for recto-vaginal fistulas as complex or simple. Classification of fistula is performed to plan proper treatment and appropriate therapy. Fistulas greater than 2.5 cm in diameter are termed as large and those less than 2.5 cm are considered small. Hence, healthcare practitioners in the recto-vaginal fistula treatment market are increasing R&D to boost availability of therapeutics.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Recto-vaginal Fistula Treatment Market

Robust Healthcare Infrastructure in North America Helps Increase Patient Outcomes

North America is anticipated to dominate the global recto-vaginal fistula treatment market from 2021 to 2031. This can be attributed to favorable regulatory environment, rise in focus and interest in recto-vaginal fistula research & development (R&D), and government funding for life sciences research. Additionally, well-established and high quality infrastructure are driving the North America recto-vaginal fistula treatment market. The market in Asia Pacific is expected to grow at a rapid pace during the forecast period due to rise in R&D activities, increase in government initiatives for improving healthcare, and surge in focus of key players on building or strengthening presence in the region.

Governments of developing countries are making significant investments to modernize healthcare infrastructure in their respective countries, which is likely to increase access to healthcare. This is projected to fuel the demand for recto-vaginal fistula treatment.

Recto-vaginal Fistula Treatment Market: Overview

  • Recto-vaginal fistula is an abnormal connection between lower portions of large intestine-rectum-vagina. Causes of rectovaginal fistula include Crohn's disease, cancer or radiation treatment in pelvic area, surgery involving vagina, perineum, rectum or anus, and injuries during childbirth.
  • Fistula connects to surfaces or lumens. It begins on the offending side and makes its way to an adjacent lumen or surface. It follows the easiest and shortest path to the adjacent organ. Recto-vaginal fistula starts from the rectum and extends to the vagina. It is not a healthy situation or physiological status. There is usually an underlying pathology, injury, or surgical event. Characteristics of rectovaginal fistula (RVF), such as site, size, length, activity, and symptoms, vary depending on the cause of the fistula, patient factors, and the treatment received. It is a potentially challenging surgical condition for both the patient and the healthcare team. The underlying etiology determines the method of assessment, management, and prognosis.
  • The frequency of recto-vaginal fistula varies according to the cause. These are typically classified by etiology, location, and size, which affect the treatment and prognosis. Recto-vaginal fistulas are divided into two groups by location:
  • Low RVFs are located in the lower third of the rectum and the lower half of the vagina. These are closest to the anus and are repaired with a perineal surgical approach.
  • High RVFs are located between the middle third of the rectum and the posterior vaginal fornix. These require a transabdominal surgical repair approach.
  • Most RVFs are less than 2 cm in diameter and are stratified by size:
    • Small: Less than 0.5 cm in diameter
    • Medium-sized: 0.5 to 2.5 cm in diameter
    • Large RVFs: Exceed 2.5 cm in diameter

Recto-vaginal Fistula Treatment Market: Drivers

  • Rise in prevalence of Crohn’s disease leading to the occurrence of recto-vaginal fistula drives the global recto-vaginal fistula treatment market. Crohn's disease can be defined as an inflammatory bowel disease, wherein there is an inflammation of the digestive tract lining. Large number of women suffering from Crohn’s disease never develop recto-vaginal fistula. However, Crohn’s disease increases the risk of this condition. Hence, prevalence of recto-vaginal fistula is projected to rise during the forecast period owing to increase in incidence of Crohn’s disease.
  • Delivery-related injuries is the most common factor causing recto-vaginal fistulas. This includes perineum tear that extends to the bowel or an episiotomy infection, which is a surgical incision conducted to enlarge the perineum during the course of vaginal delivery. These could occur post a long, difficult, or otherwise obstructed labor. These kinds of fistula could also comprise injury to anal sphincter, the muscle rings at the end of the rectum that aid a person to hold. Hence, the incidence rate of recto-vaginal fistula is likely to increase due to rise in the rate of childbirth injuries during the forecast period.
  • Presence of cancerous tumor in regions, such as uterus, rectum, vagina, anal canal or cervix, can lead to development of recto-vaginal fistula. Moreover, radiation therapy undertaken to treat cancer in these body parts increases the risk of development of recto-vaginal fistulas. Past surgery in lower pelvic region, such as hysterectomy, could also result in development of recto-vaginal fistula. Therefore, rise in prevalence of pelvic cancer and surgery in lower pelvic region are projected to drive the global recto-vaginal fistula market.

Market Segmentation: Recto-vaginal Fistula Treatment Market

  • In terms of type, the global recto-vaginal fistula treatment market has been classified into high rectovaginal fistula, low rectovaginal fistula, and midzone fistula
  • Based on end-user, the global Rectovaginal fistula treatment market has been categorized into hospitals, ambulatory surgical centers, and others
  • In terms of treatment, the global recto-vaginal fistula treatment market has been bifurcated into medication and surgery
  • Based on indication, the global recto-vaginal fistula treatment market has been divided into Crohn's disease, delivery-related injuries, cancerous tumor treatment, and others
  • Each of the segments has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights. The Recto-vaginal fistula treatment market report provides current and expected revenue (US$ Mn) for each of these segments from 2021 to 2031, considering 2020 as the base year. The compound annual growth rate (percentage CAGR) has been provided for each segment and market from 2021 to 2031 along with market size estimations.

Regional Overview: Recto-vaginal Fistula Treatment Market

  • In terms of region, the global recto-vaginal fistula treatment market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa
  • The recto-vaginal fistula treatment market in North America was valued at US$ 148.7 Mn in 2020 and is projected to reach US$ 325.8 Mn by 2031, expanding at a CAGR of 7.2% from 2021 to 2031
  • Growth of the market in the region can be attributed to favorable regulatory environment, rise in focus and interest in recto-vaginal fistula research & development, and government funding for life sciences research. Additionally, well-established and high quality infrastructure drives the market in North America.

Major Players: Recto-vaginal Fistula Treatment Market

  • The recto-vaginal fistula treatment market report concludes with the company profiles section, which includes key information about major players in the global recto-vaginal fistula treatment market
  • Leading players analyzed in the report include Pfizer, Inc., GlaxoSmithKline plc, Sanofi S.A., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services, Inc., W. L. Gore & Associates, Inc., Mount Sinai Hospital, Tubingen University Hospital, St. Mark's Hospital, Apollo Hospitals Enterprise Ltd., and other prominent players
  • Each of these players has been profiled in the recto-vaginal fistula treatment market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments

Recto-vaginal Fistula Treatment Market Snapshot

Attribute

Detail

Market Size Value in 2020

US$ 550.8 Mn

Market Forecast Value in 2031

US$ 1,034.3 Mn

Growth Rate (CAGR)

5.7%

Forecast Period

2021–2031

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market player - Competition Matrix (by tier and size of companies)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • By Type
    • High Recto-vaginal Fistula
    • Low Recto-vaginal Fistula
    • Midzone Fistula
  • By End-user
    • Hospitals
    • Ambulatory Surgical Centers
    • Others
  • By Indication
    • Crohn's Disease
    • Delivery-related Injuries
    • Cancerous Tumor Treatment
    • Others
  • By Treatment
    • Medication
      • Antibiotics
      • Biologics Therapy
    • Surgery
      • Sphincteroplasty Procedure
      • Endorectal Advancement Flap Procedure
      • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Pfizer, Inc.
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited
  • Johnson & Johnson Services, Inc.
  • W. L. Gore & Associates, Inc.
  • Mount Sinai Hospital
  • Tubingen University Hospital
  • St. Mark's Hospital
  • Apollo Hospitals Enterprise Ltd.
  • Other prominent players

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

Recto-vaginal fistula treatment market is expected to cross the value of US$ 1 Bn by the end of 2031

Recto-vaginal fistula treatment market is estimated to expand at a CAGR of 5.7% from 2021 to 2031

Recto-vaginal fistula treatment market is driven by rise in prevalence of Crohn’s disease resulting in the occurrence of recto-vaginal fistula.

The high recto-vaginal fistula segment is projected to account for major share of the market by 2031

Key players operating in the global market include Pfizer, Inc., GlaxoSmithKline plc, Sanofi S.A., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services, Inc.

Recto-vaginal Fistula Treatment Market – Scope of Report

TMR’s report on the global recto-vaginal fistula treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global recto-vaginal fistula treatment market for the period 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global recto-vaginal fistula treatment market from 2021 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the recto-vaginal fistula treatment market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global recto-vaginal fistula treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report recto-vaginal fistula treatment market light on the changing competitive dynamics in the global recto-vaginal fistula treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global recto-vaginal fistula treatment market.

The report delves into the competition landscape of the global recto-vaginal fistula treatment market. Key players operating in the global recto-vaginal fistula treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global recto-vaginal fistula treatment market profiled in this report.

Key Questions Answered in Global Recto-vaginal Fistula Treatment Market Report

  • What is the sales/revenue generated by recto-vaginal fistula across all regions during the forecast period?
  • What are the opportunities in the global recto-vaginal fistula treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Recto-vaginal Fistula Treatment Market – Research Objectives and Research Approach

The comprehensive report on the global recto-vaginal fistula treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global recto-vaginal fistula market in terms of type, end-user, indication, treatment, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global recto-vaginal fistula treatment market.

Recto-vaginal Fistula Treatment Market – Segmentation

TMR’s study on the global recto-vaginal fistula treatment market includes information divided into three segments: type, end-user, indication, treatment, and region. Changing industry trends and other market dynamics associated with these segments of the global recto-vaginal fistula treatment market are discussed in detail.

Type
  • High Recto-vaginal Fistula
  • Low Recto-vaginal Fistula
  • Midzone Fistula
End-user
  • Hospitals
  • Ambulatory Surgical Center
  • Others
Indication
  • Crohn's Disease
  • Delivery-related Injuries
  • Cancerous Tumor Treatment
  • Others
Treatment
  • Medication
    • Antibiotics
    • Biologics Therapy
  • Surgery
    • Sphincteroplasty Procedure
    • Endorectal Advancement Flap Procedure
    • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Recto-vaginal Fistula Treatment Market

4. Market Overview

    4.1. Introduction

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Recto-vaginal Fistula Treatment Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Advancements & Innovations in Treatment Methods/Medications

    5.2. Disease Epidemiology Analysis

    5.3. Key Industry Events (mergers, acquisitions, agreements / partnerships, etc.)

    5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Recto-vaginal Fistula Treatment Market Analysis and Forecast, by Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Type, 2017–2031

        6.3.1. High Recto-vaginal Fistula

        6.3.2. Low Recto-vaginal Fistula

        6.3.3. Midzone Fistula

    6.4. Market Attractiveness Analysis, by Type

7. Global Recto-vaginal Fistula Treatment Market Analysis and Forecast, by End-user

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by End-user, 2017–2031

        7.3.1. Hospitals

        7.3.2. Ambulatory Surgical Centers

        7.3.3. Others

    7.4. Market Attractiveness Analysis, by End-user

8. Global Recto-vaginal Fistula Treatment Market Analysis and Forecast, by Treatment

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by Treatment, 2017–2031

        8.3.1. Medication

            8.3.1.1. Antibiotics

            8.3.1.2. Biologics Therapy

        8.3.2. Surgery

            8.3.2.1. Sphincteroplasty Procedure

            8.3.2.2. Endorectal Advancement Flap Procedure

            8.3.2.3. Others

    8.4. Market Attractiveness Analysis, by Treatment

9. Global Recto-vaginal Fistula Treatment Market Analysis and Forecast, by Indication

    9.1. Introduction & Definition

    9.2. Key Findings / Developments

    9.3. Market Value Forecast, by Indication, 2017–2031

        9.3.1. Crohn's Disease

        9.3.2. Delivery-related Injuries

        9.3.3. Cancerous Tumor Treatment

        9.3.4. Others

    9.4. Market Attractiveness Analysis, by Indication

10. Global Recto-vaginal Fistula Treatment Market Analysis and Forecast, by Region

    10.1. Key Findings

    10.2. Market Value Forecast, by Region

        10.2.1. North America

        10.2.2. Europe

        10.2.3. Asia Pacific

        10.2.4. Latin America

        10.2.5. Middle East & Africa

    10.3. Market Attractiveness Analysis, by Country/Region

11. North America Recto-vaginal Fistula Treatment Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Type, 2017–2031

        11.2.1. High Recto-vaginal Fistula

        11.2.2. Low Recto-vaginal Fistula

        11.2.3. Midzone Fistula

    11.3. Market Value Forecast, by End-user, 2017–2031

        11.3.1. Hospitals

        11.3.2. Ambulatory Surgical Centers

        11.3.3. Others

    11.4. Market Value Forecast, by Treatment, 2017–2031

        11.4.1. Medication

            11.4.1.1. Antibiotics

            11.4.1.2. Biologics Therapy

        11.4.2. Surgery

            11.4.2.1. Sphincteroplasty Procedure

            11.4.2.2. Endorectal Advancement Flap Procedure

            11.4.2.3. Others

    11.5. Market Value Forecast, by Indication, 2017–2031

        11.5.1. Crohn's Disease

        11.5.2. Delivery-related Injuries

        11.5.3. Cancerous Tumor Treatment

        11.5.4. Others

    11.6. Market Value Forecast, by Country, 2017–2031

        11.6.1. U.S.

        11.6.2. Canada

    11.7. Market Attractiveness Analysis

        11.7.1. By Type

        11.7.2. By End-user

        11.7.3. By Treatment

        11.7.4. By Indication

        11.7.5. By Country

12. Europe Recto-vaginal Fistula Treatment Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Type, 2017–2031

        12.2.1. High Recto-vaginal Fistula

        12.2.2. Low Recto-vaginal Fistula

        12.2.3. Midzone Fistula

    12.3. Market Value Forecast, by End-user, 2017–2031

        12.3.1. Hospitals

        12.3.2. Ambulatory Surgical Centers

        12.3.3. Others

    12.4. Market Value Forecast, by Treatment, 2017–2031

        12.4.1. Medication

            12.4.1.1. Antibiotics

            12.4.1.2. Biologics Therapy

        12.4.2. Surgery

            12.4.2.1. Sphincteroplasty Procedure

            12.4.2.2. Endorectal Advancement Flap Procedure

            12.4.2.3. Others

    12.5. Market Value Forecast, by Indication, 2017–2031

        12.5.1. Crohn's Disease

        12.5.2. Delivery-related Injuries

        12.5.3. Cancerous Tumor Treatment

        12.5.4. Others

    12.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Italy

        12.6.5. Spain

        12.6.6. Rest of Europe

    12.7. Market Attractiveness Analysis

        12.7.1. By Type

        12.7.2. By End-user

        12.7.3. By Treatment

        12.7.4. By Indication

        12.7.5. By Country/Sub-region

13. Asia Pacific Recto-vaginal Fistula Treatment Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Type, 2017–2031

        13.2.1. High Recto-vaginal Fistula

        13.2.2. Low Recto-vaginal Fistula

        13.2.3. Midzone Fistula

    13.3. Market Value Forecast, by End-user, 2017–2031

        13.3.1. Hospitals

        13.3.2. Ambulatory Surgical Centers

        13.3.3. Others

    13.4. Market Value Forecast, by Treatment, 2017–2031

        13.4.1. Medication

            13.4.1.1. Antibiotics

            13.4.1.2. Biologics Therapy

        13.4.2. Surgery

            13.4.2.1. Sphincteroplasty Procedure

            13.4.2.2. Endorectal Advancement Flap Procedure

            13.4.2.3. Others

    13.5. Market Value Forecast, by Indication, 2017–2031

        13.5.1. Crohn's Disease

        13.5.2. Delivery-related Injuries

        13.5.3. Cancerous Tumor Treatment

        13.5.4. Others

    13.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.6.1. Japan

        13.6.2. China

        13.6.3. India

        13.6.4. Australia & New Zealand

        13.6.5. Rest of APAC

    13.7. Market Attractiveness Analysis

        13.7.1. By Type

        13.7.2. By End-user

        13.7.3. By Treatment

        13.7.4. By Indication

        13.7.5. By Country/Sub-region

14. Latin America Recto-vaginal Fistula Treatment Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Type, 2017–2031

        14.2.1. High Recto-vaginal Fistula

        14.2.2. Low Recto-vaginal Fistula

        14.2.3. Midzone Fistula

    14.3. Market Value Forecast, by End-user, 2017–2031

        14.3.1. Hospitals

        14.3.2. Ambulatory Surgical Centers

        14.3.3. Others

    14.4. Market Value Forecast, by Treatment, 2017–2031

        14.4.1. Medication

            14.4.1.1. Antibiotics

            14.4.1.2. Biologics Therapy

        14.4.2. Surgery

            14.4.2.1. Sphincteroplasty Procedure

            14.4.2.2. Endorectal Advancement Flap Procedure

            14.4.2.3. Others

    14.5. Market Value Forecast, by Indication, 2017–2031

        14.5.1. Crohn's Disease

        14.5.2. Delivery-related Injuries

        14.5.3. Cancerous Tumor Treatment

        14.5.4. Others

    14.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        14.6.1. Brazil

        14.6.2. Mexico

        14.6.3. Rest of LATAM

    14.7. Market Attractiveness Analysis

        14.7.1. By Type

        14.7.2. By End-user

        14.7.3. By Treatment

        14.7.4. By Indication

        14.7.5. By Country/Sub-region

15. Middle East & Africa Recto-vaginal Fistula Treatment Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Key Findings

    15.2. Market Value Forecast, by Type, 2017–2031

        15.2.1. High Recto-vaginal Fistula

        15.2.2. Low Recto-vaginal Fistula

        15.2.3. Midzone Fistula

    15.3. Market Value Forecast, by End-user, 2017–2031

        15.3.1. Hospitals

        15.3.2. Ambulatory Surgical Centers

        15.3.3. Others

    15.4. Market Value Forecast, by Treatment, 2017–2031

        15.4.1. Medication

            15.4.1.1. Antibiotics

            15.4.1.2. Biologics Therapy

        15.4.2. Surgery

            15.4.2.1. Sphincteroplasty Procedure

            15.4.2.2. Endorectal Advancement Flap Procedure

            15.4.2.3. Others

    15.5. Market Value Forecast, by Indication, 2017–2031

        15.5.1. Crohn's Disease

        15.5.2. Delivery-related Injuries

        15.5.3. Cancerous Tumor Treatment

        15.5.4. Others

    15.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        15.6.1. GCC Countries

        15.6.2. South Africa

        15.6.3. Rest of MEA

    15.7. Market Attractiveness Analysis

        15.7.1. By Type

        15.7.2. By End-user

        15.7.3. By Treatment

        15.7.4. By Indication

        15.7.5. By Country/Sub-region

16. Competition Landscape

    16.1. Market Player – Competition Matrix (by tier and size of companies)

    16.2. Company Profiles

        16.2.1. Pfizer Inc.

            16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.1.2. Company Financials

            16.2.1.3. Growth Strategies

            16.2.1.4. SWOT Analysis

        16.2.2. GlaxoSmithKline plc

            16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.2.2. Company Financials

            16.2.2.3. Growth Strategies

            16.2.2.4. SWOT Analysis

        16.2.3. Sanofi S.A.

            16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.3.2. Company Financials

            16.2.3.3. Growth Strategies

            16.2.3.4. SWOT Analysis

        16.2.4. Takeda Pharmaceutical Company Limited

            16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.4.2. Company Financials

            16.2.4.3. Growth Strategies

            16.2.4.4. SWOT Analysis

        16.2.5. Johnson & Johnson Services, Inc.

            16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.5.2. Company Financials

            16.2.5.3. Growth Strategies

            16.2.5.4. SWOT Analysis

        16.2.6. W. L. Gore & Associates, Inc.

            16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.6.2. Company Financials

            16.2.6.3. Growth Strategies

            16.2.6.4. SWOT Analysis

        16.2.7. Mount Sinai Hospital

            16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.7.2. Company Financials

            16.2.7.3. Growth Strategies

            16.2.7.4. SWOT Analysis

        16.2.8. Tubingen University Hospital

            16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.8.2. Company Financials

            16.2.8.3. Growth Strategies

            16.2.8.4. SWOT Analysis

        16.2.9. St. Mark's Hospital

            16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.9.2. Company Financials

            16.2.9.3. Growth Strategies

            16.2.9.4. SWOT Analysis

        16.2.10. Apollo Hospitals Enterprise Ltd.

            16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.10.2. Company Financials

            16.2.10.3. Growth Strategies

            16.2.10.4. SWOT Analysis

        16.2.11. Other Prominent Players

            16.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.11.2. Company Financials

            16.2.11.3. Growth Strategies

            16.2.11.4. SWOT Analysis

List of Tables

Table 01: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 02: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 03: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

Table 04: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Medication, 2017–2031

Table 05: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Surgery, 2017–2031

Table 06: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 07: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 08: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 09: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 10: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 11: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

Table 12: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Medication, 2017–2031

Table 13: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Surgery, 2017–2031

Table 14: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 15: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 16: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 17: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 18: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

Table 19: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Medication, 2017–2031

Table 20: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Surgery, 2017–2031

Table 21: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 22: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 23: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 24: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 25: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

Table 26: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Medication, 2017–2031

Table 27: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Surgery, 2017–2031

Table 28: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 29: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 30: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 31: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 32: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

Table 33: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Medication, 2017–2031

Table 34: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Surgery, 2017–2031

Table 35: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Table 36: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 37: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 38: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 39: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017–2031

Table 40: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Medication, 2017–2031

Table 41: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Surgery, 2017–2031

Table 42: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2031

List of Figures

Figure 01: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Recto-vaginal Fistula Treatment Market Value Share, by Type, 2020

Figure 03: Global Recto-vaginal Fistula Treatment Market Value Share, by Indication, 2020

Figure 04: Global Recto-vaginal Fistula Treatment Market Value Share, by End-user, 2020

Figure 05: Global Recto-vaginal Fistula Treatment Market Value Share, by Treatment, 2020

Figure 06: Global Recto-vaginal Fistula Treatment Market Value Share Analysis, by Type, 2020 and 2031

Figure 07: Global Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Type, 2021–2031

Figure 08: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by High Recto-vaginal Fistula, 2017–2031

Figure 09: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Low Recto-vaginal Fistula, 2017–2031

Figure 10: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Midzone Fistula, 2017–2031

Figure 11: Global Recto-vaginal Fistula Treatment Market Value Share Analysis, by End-user, 2020 and 2031

Figure 12: Global Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by End-user, 2021–2031

Figure 13: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Hospitals, 2017–2031

Figure 14: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Ambulatory Surgical Centers, 2017–2031

Figure 15: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Others, 2017–2031

Figure 16: Global Recto-vaginal Fistula Treatment Market Value Share Analysis, by Treatment, 2020 and 2031

Figure 17: Global Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Treatment, 2021–2031

Figure 18: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Medication, 2017–2031

Figure 19: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Surgery, 2017–2031

Figure 20: Global Recto-vaginal Fistula Treatment Market Value Share Analysis, by Indication, 2020 and 2031

Figure 21: Global Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Indication 2021–2031

Figure 22: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Crohn's Disease, 2017–2031

Figure 23: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Delivery-related Injuries, 2017–2031

Figure 24: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Cancerous Tumor Treatment, 2017–2031

Figure 25: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Delivery-related Injuries, 2017–2031

Figure 26: Global Recto-vaginal Fistula Treatment Market Value Share Analysis, by Region, 2020 and 2031

Figure 27: Global Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Region, 2021–2031

Figure 28: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 29: North America Recto-vaginal Fistula Treatment Market Value Share, by Country, 2020–2031

Figure 30: North America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Country, 2021–2031

Figure 31: North America Recto-vaginal Fistula Treatment Market Value Share Analysis, by Type, 2020 and 2031

Figure 32: North America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Type, 2021–2031

Figure 33: North America Recto-vaginal Fistula Treatment Market Value Share Analysis, by End-user, 2020 and 2031

Figure 34: North America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by End-user, 2021–2031

Figure 35: North America Recto-vaginal Fistula Treatment Market Value Share Analysis, by Treatment, 2020 and 2031

Figure 36: North America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Treatment, 2021–2031

Figure 37: North America Recto-vaginal Fistula Treatment Market Value Share Analysis, by Indication, 2020 and 2031

Figure 38: North America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Indication 2021–2031

Figure 39: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 40: Europe Recto-vaginal Fistula Treatment Market Value Share, by Country/Sub-region, 2020–2031

Figure 41: Europe Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 42: Europe Recto-vaginal Fistula Treatment Market Value Share Analysis, by Type, 2020 and 2031

Figure 43: Europe Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Type, 2021–2031

Figure 44: Europe Recto-vaginal Fistula Treatment Market Value Share Analysis, by End-user, 2020 and 2031

Figure 45: Europe Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by End-user, 2021–2031

Figure 46: Europe Recto-vaginal Fistula Treatment Market Value Share Analysis, by Treatment, 2020 and 2031

Figure 47: Europe Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Treatment, 2021–2031

Figure 48: Europe Recto-vaginal Fistula Treatment Market Value Share Analysis, by Indication, 2020 and 2031

Figure 49: Europe Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Indication 2021–2031

Figure 50: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 51: Asia Pacific Recto-vaginal Fistula Treatment Market Value Share, by Country/Sub-region, 2020–2031

Figure 52: Asia Pacific Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 53: Asia Pacific Recto-vaginal Fistula Treatment Market Value Share Analysis, by Type, 2020 and 2031

Figure 54: Asia Pacific Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Type, 2021–2031

Figure 55: Asia Pacific Recto-vaginal Fistula Treatment Market Value Share Analysis, by End-user, 2020 and 2031

Figure 56: Asia Pacific Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by End-user, 2021–2031

Figure 57: Asia Pacific Recto-vaginal Fistula Treatment Market Value Share Analysis, by Treatment, 2020 and 2031

Figure 58: Asia Pacific Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Treatment, 2021–2031

Figure 59: Asia Pacific Recto-vaginal Fistula Treatment Market Value Share Analysis, by Indication, 2020 and 2031

Figure 60: Asia Pacific Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Indication 2021–2031

Figure 61: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 62: Latin America Recto-vaginal Fistula Treatment Market Value Share, by Country/Sub-region, 2020–2031

Figure 63: Latin America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 64: Latin America Recto-vaginal Fistula Treatment Market Value Share Analysis, by Type, 2020 and 2031

Figure 65: Latin America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Type, 2021–2031

Figure 66: Latin America Recto-vaginal Fistula Treatment Market Value Share Analysis, by End-user, 2020 and 2031

Figure 67: Latin America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by End-user, 2021–2031

Figure 68: Latin America Recto-vaginal Fistula Treatment Market Value Share Analysis, by Treatment, 2020 and 2031

Figure 69: Latin America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Treatment, 2021–2031

Figure 70: Latin America Recto-vaginal Fistula Treatment Market Value Share Analysis, by Indication, 2020 and 2031

Figure 71: Latin America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Indication 2021–2031

Figure 72: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 73: Middle East & Africa Recto-vaginal Fistula Treatment Market Value Share, by Country/Sub-region, 2020–2031

Figure 74: Middle East & Africa Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 75: Middle East & Africa Recto-vaginal Fistula Treatment Market Value Share Analysis, by Type, 2020 and 2031

Figure 76: Middle East & Africa Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Type, 2021–2031

Figure 77: Middle East & Africa Recto-vaginal Fistula Treatment Market Value Share Analysis, by End-user, 2020 and 2031

Figure 78: Middle East & Africa Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by End-user, 2021–2031

Figure 79: Middle East & Africa Recto-vaginal Fistula Treatment Market Value Share Analysis, by Treatment, 2020 and 2031

Figure 80: Middle East & Africa Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Treatment, 2021–2031

Figure 81: Middle East & Africa Recto-vaginal Fistula Treatment Market Value Share Analysis, by Indication, 2020 and 2031

Figure 82: Middle East & Africa Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Indication 2021–2031

Figure 83: Global Recto-vaginal Fistula Treatment Market Share, by Company, 2020

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Recto-vaginal Fistula Treatment Market